Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Preddator Low-volume Microplate Dispenser Awarded ELRIG Prize

Published: Wednesday, July 10, 2013
Last Updated: Wednesday, July 10, 2013
Bookmark and Share
Recognizing technology’s novel method of improving liquid handling efficiency.

Redd&Whyte has announced that its innovative Preddator low-volume microplate dispenser has been awarded the “ELRIG Technology Prize”, which recognizes the most interesting automation seen at the recent ELRIG Robotics and Automation Conference.

The award was voted for by delegates at the ELRIG Robotics and Automation show, in recognition of the fact that the Redd&Whyte Preddator nano dispenser has a unique design that is capable of precisely dispensing a wide range of fluid types and cell suspensions into any microplate format from 96-3456 wells.

The Preddator is an ideal research tool for a wide range of applications including: assay development, protein dispensing, DMSO backfilling, silicon oil deposition and PCR master mix preparation.

The system can be used as a stand-alone system or can be integrated into a range of different automated assay preparation and screening systems.

This award winning version of the Preddator is currently in operation at several of the top 10 pharma companies, where it is being successfully used in compound screening groups where consistency of assay data and reduction in assay costs are critical.

Roger Poole, Managing Director of Redd&Whyte said: “Redd&Whyte is honoured to be chosen for this prestigious ELRIG award. For the Preddator system to be acknowledged for liquid handling innovation alongside products from some of the world’s top automation firms is a great endorsement. This is a competition judged by ELRIG delegates and as such is very valuable recognition of the unique contribution Preddator can make to any compound screening workflow.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Redd&Whyte Appoints HighRes Biosolutions as New US Distributor
Appointment offers US scientists specialist access to its unique liquid handling technology.
Thursday, February 28, 2013
Redd&Whyte Appoints New UK Sales Manager
Appointment to provide professional service and support for UK scientists.
Thursday, February 21, 2013
Redd&Whyte Appoints New Director of Business Development
Appointment of Rob Harkness as part of new growth strategy.
Thursday, August 23, 2012
Redd&Whyte wins Best New Company at the Life Science Awards
Redd&Whyte was awarded Best New Company at the inaugural Life Science Awards, on 29 June in Hamburg, Germany, preceding the first European Lab Automation conference and exhibition.
Thursday, July 07, 2011
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Preventing Breast Cancer with Hops
Study of hops extract suggests prevention of breast cancer through chemical pathway activation.
Treatment Advancement for Gaucher and Parkinson's Diseases
NIH scientists identify molecule that may act as a possible treatment of neurological diseases.
Biomunex Confirms Optimal Properties and Activity of BiXAb® Antibodies
Biomunex‘s Plug-and-Play bispecific antibodies demonstrated excellent in vitro properties and in vivo activity positively differentiating their BiXAb platform from competing formats.
Liquid Biopsy Predicts Colon Cancer Recurrence
Scientists have used a genetic test that spots bits of cancer-related DNA circulating in the blood to accurately predict the likelihood of the disease’s return in some — but not all — of a small group of patients with early-stage colon cancer.
New Treatment for Rare Blood Cancers
Drug called midostaurin showed promise in an international clinical trial led by a Stanford physician.
Biomarker for Parkinson's Disease Found in Urine Samples
Protein identified as Parkinson's biomarker sourced from patient's stored frozen urine samples.
Testing for Malaria or Cancer at Home
Chemist develops tech to save lives in rural Africa.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!